Key result
Transcatheter ablation eliminates incessant idiopathic LV fascicular tachycardia in an infant, restoring LVEF to 70%.
Case Report (n=1)
Transcatheter ablation can be a safe and effective curative treatment for tachycardiomyopathy secondary to incessant fascicular ventricular tachycardia in infants, leading to complete recovery of systolic function.
Answers are grounded in this paper and cite their sources.
May support screening for tachycardia-mediated LV dysfunction in pediatric cardiomyopathy; leaves open need for prospective trials before practice change.
Cardiomyopathies in the paediatric population portend a poor prognosis being characterized by a particularly accelerated and therapy refractory clinical course.1,2 Recognition and effective treatment of potential secondary causes may play a crucial role, leading to recovery in a not negligible proportion of cases. Left-ventricular dysfunction associated with wide QRS tachycardia is a quite common presentation, depicting two possible clinical pictures: ventricular tachycardia complicating idiopathic cardiomyopathy and primary tachycardiomyopathy. The distinction between the two might be pivotal, particularly in the paediatric population since, recognition of a tachycardiomyopathy must prompt an aggressive rhythm control. In this context, the role of the conduction system is being recognized in many incessant tachycardias with or without an underlying structural heart disease.3,4 The two most clinically relevant scenarios are fascicular tachycardia and junctional ectopic tachycardia (JET).5 The former is usually sustained by a reentry within a diseased Purkinjie network or involving the surrounding ventricular myocardium. The latter is thought to be caused by abnormal automaticity within the atrioventricular junction, and thus usually display a narrow QRS. Although JET is more frequently associated with a known structural injury such as myocarditis or post-operative status, still it should be kept in mind in the differential diagnosis, since isolated-idiopathic cases have been described as well.6 These arrhythmias, when displaying an incessant course may be responsible for systolic impairment, independent of their specific individual prognosis.7 We are describing a case of a 12-month-old baby that presented with a severe systolic dysfunction and almost incessant wide QRS tachycardia causing rapidly worsening heart failure despite full medical therapy. The arrhythmia was finally diagnosed as idiopathic left-ventricular fascicular tachycardia (ILVT) at the invasive electrophysiologic study, and transcatheter ablation through transseptal route was performed. The procedure turned out to be effective both in eliminating the arrhythmia and allowing complete clinical and functional recovery. A 12-month-old baby was referred to our centre owing to almost incessant ventricular tachycardia that was suspected to be responsible for tachycardiomyopathy with severe depression of the systolic left-ventricular function. She was previously admitted to a general paediatric ward due to respiratory distress. The baby was clearly polipnoic with hepatomegalia. The past medical history was completely silent; in particular, she was delivered at term and did well until few weeks before admission. She weighed 10 kg with a body surface area of 0.41 m2 (between the 50th and 97th percentile) The electrocardiogram (ECG) recordings showed a nearly incessant wide QRS complex tachycardia (cycle length 300 ms) with right bundle branch block morphology and superior axis on the frontal plane consistent with the diagnosis of fascicular tachycardia. During continuous monitoring we had the chance to observe an intriguing transient exact doubling of the arrhythmia cycle length suggesting a 2:1 exit block phenomenon. Chest X-rays showed a clearly enlarged cardiac silhouette (cardiothoracic ratio 0.7) (Figure 1). This finding was confirmed by the echocardiographic examination which disclosed a dilated and severely hypokinetic left ventricle (end diastolic/end systolic diameters 38/30 mm), ejection fraction was estimated to 25% with moderate valve regurgitation secondary to annulus dilatation. Trial of betablockers, verapamil, and amiodarone were attempted, even in association and uptitrated to maximal dose. In particular, the association between amiodarone 15 mg/kg and metoprolol 1 mg/kg bid (twice a day), achieved a slight increase of the tachycardia cycle length (375 ms) (Figure 2) along with a transient and partial clinical benefit. This partial result allowed a slight systolic performance recovery (left-ventricular ejection fraction (LVEF) increase to 30–35%) reinforcing the hypothesis of a functional depression secondary to a tachycardiomyopathy. After a short period the patient showed clinical sign of a progressive haemodynamic derangement, and thus she was scheduled for a bailout ablation procedure. The procedure was carried out during general anaesthesia. A single-catheter approach was selected to minimize invasiveness. The patient was almost persistently in ventricular tachycardia. A mapping catheter (St Jude Therapy 4 mm, B-curve) was first advanced in the His region to elucidate arrhythmia mechanism. Ventricular–atrial dissociation and a shorter His to ventricle interval during tachycardia than during sinus rhythm strongly suggested a fascicular VT arising from the posterior fascicle (right bundle branch block+superior axis at surface ECG). We then sought to negotiate the catheter in the left atrium through the septum in the hypothesis of a patent foramen ovale but we failed. A long-sheath St Jude SL1 was then introduced and a standard transseptal puncture performed by means of a Brockenbrough needle (Figure 3A). The catheter was then fed in the left ventricle and septal left side was extensively mapped. A late diastolic pre-Purkinje potential could be recorded at the inferior mid-basal aspect of the interventricular septum, preceding a sharp Purkinje potential almost fused with ventricular signal (Figure 3B). Pacing from this site demonstrated concealed entrainment (QRS morphology identical during pacing and during tachycardia) with a postpacing interval equal to the cycle length of VT. Moreover the stimulus to QRS interval was equal to the Purkinje potential to QRS interval during VT. During the short periods of sinus rhythm the tachycardia was inducible with programmed ventricular stimulation suggesting a reentry as tachycardia underlying mechanism. Chest X-ray showing increased cardiothoracic ratio. Twelve-lead electrocardiogram during tachycardia exhibits a right bundle branch block morphology and superior axis. (A) Fluoroscopic image showing the position of the ablation catheter at the site of successful ablation (antero-posterior fluoroscopic view, transeptal approach). (B) Intracardiac bipolar signal at site of successful ablation: note the sharp pre-systolic activity preceded by a low amplitude rapid mid-diastolic deflection. Radiofrequency energy (30 W, 65 °C, 60 s; average total energy delivered 2.6 kJ) was delivered at this site achieving interruption of the arrhythmia during ablation after 15 s. During sinus rhythm an adjunctive safety radiofrequency (RF) pulse was delivered without impairing conduction along the left bundle and the fascicula. After 45 min of observation, only single ventricular beats with the same morphology of the clinical one were recorded and no sustained ventricular arrhythmias were inducible with incremental and programmed atrial/ventricular stimulation. Continuous ECG monitoring showed short runs of clinical VT in the first days after procedure. Due to this behaviour we decided to implant a subcutaneous continuous monitoring device (Reveal XT, Medtronic, Minneapolis USA) equipped with remote monitoring (CARE-LINK, Medtronic), in order to be able to weigh arrhythmic burden against ventricular function over time. During follow-up the trivial remnant arrhythmic burden kept decreasing. At 3 months complete cleaning from any arrhythmia along with a dramatic improvement of the systolic function (LVEF 70%) were observed. This favourable outcome was maintained at 24 months after tapering and discontinuation of the antiarrhyhmic therapy. The differential diagnosis between ventricular tachycardia arising in the setting of a cardiomyopathy and tachycardiomyopathy is pivotal in the management of infants presenting with an incessant ventricular tachycardia and signs of heart failure. When tachycardiomyopathy is diagnosed, an aggressive arrhythmia treatment is prompted since it may lead to complete recovery. However, such a diagnosis is always done ‘ex iuvantibus’ meaning that resolution of systolic dysfunction after arrhythmia control, either pharmacological or invasive, allows to elucidate the diagnosis (up to 7% of such cases are due to tachycardiomyopathy and recovered after successful ablation in the UK registry.8 It follows that an ablation attempt may be warranted when tachycardiomyopathy is suspected and arrhythmias are not enough controlled with drugs. In our case we proceeded to ablation despite the age and weight limit suggested by the international statements since the clinical course kept on deteriorating despite partial control of arrhythmias achieved on full therapy. From the technical standpoint, few issues deserve discussion. The potential recorded at the site of successful ablation displayed two pre-systolic components. This finding reproduce a previous observation supporting the notion of a macroreentrant circuit involving the septal Purkinje network and the surrounding myocardial tissue, as the putative mechanism of ILVT. In this view the dull late-diastolic signal (pre-Purkinje potential) represents the diastolic path of the circuit and precedes the typical sharp Purkinje potential that is almost fused with ventricular activation.9 The pre-Purkinje potential should be sought as the most reliable site of ablation even in infants, whereas targeting ablation spots displaying single Purkinje potential anticipating the ventricular activation might be responsible for a not negligible procedural failure. Our observation of a likely transient 2:1 block might be strengthen this concept, demonstrating that the exit path is not active part of the circuit. Little is know about the preferred way (i.e. transseptal vs. aortic retrograde) to access left chambers and choice is mainly based on operator expertise, patient characteristics, and the supposed anatomic region of interest. General statements about this point are definitely lacking in the paediatric setting, therefore the operative strategy is mainly constrained by safety issues. We performed the ablation through the transseptal route in order to avoid the bulky effect of the catheter across the small aortic orifice which could have led to even fatal consequences, particularly in such compromised patient. Moreover as general believing the small size of the arterial structures and aortic root definitely increase the risk of vascular complications and limit manoeuvrability of the ablation catheter. 10,11 Conventional RF energy was employed instead of cryo, balancing the benefit of a more predictable and long-term-effective lesion against the risk of permanent and clinically relevant damage to the conduction tissue, that we estimated to be quite low. Finally, a subcutaneous monitoring device was implanted, as we were concerned by the potential variable clustering of arrhythmias during follow-up, making conventional periodic random ECG Holter recording not completely reliable. The baby was discharged with single ventricular ectopies and short runs of fascicular ventricular tachycardia that progressively disappeared in the first months after ablation. This behaviour may be explained by an enlargement of RF lesion over time that could have completed a partial acute result. The enlargement of RF lesions in immature heart has been described in infant lambs and appears to be due to both lesion stretch and actual growth of the lesion constituents.12 This issue should be taken into account as an adjunctive variable when tailoring total energy to be delivered in paediatric population, particularly in the perspective of alternative energies sources. Tachycardiomyopathy should always be considered as a possible reversible cause of ventricular dysfunction in the paediatric population. Aggressive antiarrhythmic treatment is potentially able to completely revert an otherwise rapidly progressing heart failure. When pharmacological therapy fails, transcatheter ablation may be early considered in the plan of the therapeutic strategy. Conflict of interest: none declared.
No takes yet. Share an insight, caveat, or question.
Filippo et al. (2011) conducted a case report in Severe ventricular systolic dysfunction and incessant ventricular tachycardia (n=1). Transcatheter ablation was evaluated on Clinical and functional recovery. Transcatheter ablation successfully eliminated incessant idiopathic left-ventricular fascicular tachycardia in a 12-month-old infant, allowing complete clinical and functional recovery.
Synapse has enriched 10 related papers. Consider them for comparative context: